About Cellective BioTherapy
Cellective BioTherapy is a company based in Durham (United States) founded in 2015.. Cellective BioTherapy has raised $2.5 million across 1 funding round from investors including Eshelman Ventures. Cellective BioTherapy operates in a competitive market with competitors including Be Bio, Immusoft, JW Therapeutics, Walking Fish Therapeutics and Overland Pharmaceuticals, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.5 M (USD)
in 1 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
May 26, 2015
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cellective BioTherapy
Cellective BioTherapy has successfully raised a total of $2.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.5 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.5M
-
First Round
First Round
(26 May 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2015 | Amount | Seed - Cellective BioTherapy | Valuation | Eshelman Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellective BioTherapy
Cellective BioTherapy has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Eshelman Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellective BioTherapy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellective BioTherapy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellective Biotherapy Comparisons
Competitors of Cellective BioTherapy
Cellective BioTherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Be Bio, Immusoft, JW Therapeutics, Walking Fish Therapeutics and Overland Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
B cell therapies are developed for oncology and rare diseases.
|
|
| domain | founded_year | HQ Location |
B cells are programmed as biofactories for therapeutic protein delivery.
|
|
| domain | founded_year | HQ Location |
Cell immunotherapy products are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Cell-based therapeutics for cancer and immunological disorders are developed.
|
|
| domain | founded_year | HQ Location |
-
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cellective BioTherapy
When was Cellective BioTherapy founded?
Cellective BioTherapy was founded in 2015.
Where is Cellective BioTherapy located?
Cellective BioTherapy is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is Cellective BioTherapy a funded company?
Cellective BioTherapy is a funded company, having raised a total of $2.5M across 1 funding round to date. The company's 1st funding round was a Seed of $2.5M, raised on May 26, 2015.
What does Cellective BioTherapy do?
Cellective BioTherapy was founded in 2015 and is based in Durham, United States. Operations center on the biotechnology sector, where B cell-based cellular therapies are developed to address cancers, autoimmunity, and immunodeficiency. Human B cells are expanded ex vivo through proprietary technology for autologous immunotherapy applications, including treatments for immunodeficiency. The companys domain is cellectivebiotherapy.com.
Who are the top competitors of Cellective BioTherapy?
Cellective BioTherapy's top competitors include Be Bio, Immusoft and JW Therapeutics.
Who are Cellective BioTherapy's investors?
Cellective BioTherapy has 1 investor. Key investors include Eshelman Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.